Stockscreener 앱 받기
12.79
1.39%
0.175
시간 외 거래:
12.99
0.20
+1.56%
전일 마감가:
$12.62
열려 있는:
$12.6
하루 거래량:
948.46K
Relative Volume:
0.40
시가총액:
$821.43M
수익:
$161.10M
순이익/손실:
$-308.60M
주가수익비율:
-2.7388
EPS:
-4.67
순현금흐름:
$-259.90M
1주 성능:
+1.63%
1개월 성능:
+33.65%
6개월 성능:
+84.83%
1년 성능:
-48.30%
1일 변동 폭
$12.57
$12.91
1주일 범위
$11.66
$13.09
52주 변동 폭
$5.90
$26.78
Arvinas Inc Stock (ARVN) Company Profile
명칭
Arvinas Inc
전화
203-535-1456
주소
395 WINCHESTER AVE, NEW HAVEN, CT
ARVN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ARVN
Arvinas Inc
|
12.79 | 806.01M | 161.10M | -308.60M | -259.90M | -4.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.48 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
718.36 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.12 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
901.17 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.00 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Arvinas Inc Stock (ARVN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-15 | 다운그레이드 | Goldman | Neutral → Sell |
| 2025-09-24 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-09-17 | 재개 | Barclays | Overweight |
| 2025-06-02 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2025-05-05 | 다운그레이드 | Truist | Buy → Hold |
| 2025-05-02 | 다운그레이드 | Jefferies | Buy → Hold |
| 2025-05-02 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2025-03-13 | 다운그레이드 | Goldman | Buy → Neutral |
| 2025-03-12 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2025-03-11 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-12-10 | 개시 | BTIG Research | Buy |
| 2024-11-18 | 개시 | Stephens | Overweight |
| 2024-02-28 | 재확인 | Oppenheimer | Outperform |
| 2024-02-14 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-02-01 | 개시 | Goldman | Buy |
| 2023-12-19 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-12-06 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-11-20 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2023-10-23 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2023-06-26 | 재개 | Oppenheimer | Outperform |
| 2023-01-12 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2023-01-03 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-09-09 | 개시 | Barclays | Overweight |
| 2022-06-21 | 개시 | Jefferies | Hold |
| 2022-05-09 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2022-04-28 | 개시 | Credit Suisse | Outperform |
| 2022-04-06 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-02-11 | 재개 | BMO Capital Markets | Outperform |
| 2022-02-10 | 개시 | Wells Fargo | Overweight |
| 2022-01-19 | 개시 | Goldman | Buy |
| 2021-12-07 | 개시 | Cowen | Outperform |
| 2021-10-14 | 개시 | SVB Leerink | Outperform |
| 2021-09-30 | 개시 | Stifel | Buy |
| 2021-09-09 | 개시 | BofA Securities | Buy |
| 2021-05-21 | 개시 | UBS | Buy |
| 2021-04-21 | 개시 | Truist | Buy |
| 2021-03-31 | 개시 | BMO Capital Markets | Outperform |
| 2020-12-14 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2020-06-01 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-05-12 | 개시 | Oppenheimer | Perform |
| 2019-12-19 | 개시 | H.C. Wainwright | Buy |
| 2019-11-25 | 개시 | Guggenheim | Buy |
| 2019-10-24 | 업그레이드 | Goldman | Neutral → Buy |
| 2019-09-25 | 개시 | Wedbush | Outperform |
| 2019-09-12 | 개시 | BMO Capital Markets | Outperform |
| 2019-08-06 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-06-05 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2019-04-12 | 개시 | Evercore ISI | Outperform |
| 2018-10-22 | 개시 | Citigroup | Buy |
| 2018-10-22 | 개시 | Goldman | Neutral |
| 2018-10-22 | 개시 | Piper Jaffray | Overweight |
모두보기
Arvinas Inc 주식(ARVN)의 최신 뉴스
Why Arvinas Inc. stock could benefit from AI revolutionProfit Target & AI Forecasted Stock Moves - Newser
Why Arvinas Inc. stock is considered a top pickBear Alert & Momentum Based Trading Signals - Newser
Will Arvinas Inc. stock continue upward momentumIPO Watch & Weekly Watchlist for Hot Stocks - Newser
How the Narrative Around Arvinas Is Shifting Amid Strategic Moves and Analyst Uncertainty - Yahoo Finance
52,980 Shares in Arvinas, Inc. $ARVN Acquired by SG Americas Securities LLC - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages Arvinas, Inc. (ARVN - The National Law Review
New Highs: Why Arvinas Inc. stock remains on buy listsJuly 2025 Update & Accurate Intraday Trade Tips - BỘ NỘI VỤ
Entropy Technologies LP Purchases Shares of 32,491 Arvinas, Inc. $ARVN - MarketBeat
Arvinas Inc Stock Analysis and ForecastLow Beta Stocks & Outstanding Investment Returns - earlytimes.in
Published on: 2025-11-27 09:33:44 - BỘ NỘI VỤ
Arvinas to Present at Piper Sandler 37th Annual Healthcare Conference - GlobeNewswire
Arvinas to present vepdegestrant breast cancer data at SABCS By Investing.com - Investing.com Nigeria
Arvinas to present vepdegestrant breast cancer data at SABCS - Investing.com
Arvinas, Inc. Announces Multiple Abstract Presentations on Vepdegestrant at San Antonio Breast Cancer Symposium 2025 - Quiver Quantitative
Arvinas Announces Data Presentations from the Vepdegestrant (ARV-471) Clinical Development ... - Enidnews.com
Arvinas (NASDAQ: ARVN) showcases vepdegestrant breast cancer data at 2025 SABCS - Stock Titan
Arvinas: Approvable, But Asset Looks Mediocre, Initiating With A Hold Rating (NASDAQ:ARVN) - Seeking Alpha
Promising Biotech Stocks To ConsiderNovember 18th - MarketBeat
Can Arvinas Inc. stock beat market expectations this quarterTrend Reversal & Fast Exit/Entry Strategy Plans - newser.com
Arvinas (NASDAQ:ARVN) Stock Price Down 7%Should You Sell? - MarketBeat
Why Arvinas Inc. stock attracts high net worth investorsRate Cut & High Win Rate Trade Tips - newser.com
Is Arvinas Inc. stock attractive after correctionJuly 2025 Technicals & Long-Term Safe Investment Ideas - newser.com
Connor Clark & Lunn Investment Management Ltd. Takes Position in Arvinas, Inc. $ARVN - MarketBeat
Arvinas Inc. stock chart pattern explainedSell Signal & Technical Pattern Recognition Alerts - newser.com
Is Arvinas Inc. still worth holding after the dipFed Meeting & Target Return Focused Stock Picks - newser.com
Arvinas Inc. (ARVN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Is Arvinas Inc. stock a top pick in earnings seasonJuly 2025 Earnings & Long-Term Safe Return Strategies - newser.com
Reversal indicators forming on Arvinas Inc. stockWeekly Stock Summary & AI Forecast Swing Trade Picks - newser.com
How Arvinas Inc. stock benefits from strong dollarForecast Cut & Real-Time Market Trend Scan - newser.com
Can Arvinas Inc. stock beat analyst upgradesQuarterly Performance Summary & Expert Curated Trade Ideas - newser.com
Arvinas (NASDAQ:ARVN) Shares Gap UpShould You Buy? - MarketBeat
Can technical indicators confirm Arvinas Inc.’s reversalJuly 2025 Macro Moves & Free Daily Entry Point Trade Alerts - newser.com
Arvinas, Inc.Common Stock (NQ: ARVN - FinancialContent
Arvinas’ Stock Surge: Analyzing the Movement - StocksToTrade
Arvinas (ARVN) Soars 14% as Investors Cheer Pipeline Reset and Jefferies Update - ts2.tech
ARVN: LRRK2 and PSP lead a focused pipeline, with major data and partnership milestones expected by 2026 - TradingView
Revisiting the Narrative for Arvinas as Analyst Views Shift with New Pipeline and Partner Risks - Yahoo Finance
Is Arvinas Inc. stock affected by interest rate hikesSell Signal & Reliable Price Action Trade Plans - newser.com
Arvinas Inc (ARVN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Arvinas Inc 주식 (ARVN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Morrison Briggs | Director |
Sep 22 '25 |
Buy |
7.57 |
30,000 |
227,010 |
76,021 |
| Saik Andrew | Chief Financial Officer |
Jun 24 '25 |
Sale |
7.61 |
5,700 |
43,377 |
164,401 |
1.44%
0.91%
자본화:
|
볼륨(24시간):